- Patients’ clinical characteristics.
| No. | Gender | Onset age (y) | Previous IS | Kidney biopsy | Age at RTX (y) | No. of RTX infusion | Adverse effect | Time since last infusion (y) | Last visit urine dipstick | Outcome and comments |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 4 | Pred, tac | MCD | 9 | 6 | No | 2 | - ve | Remission, off medication |
| 2 | M | 3 | Pred, MMF | MCD | 7 | 8 | No | 3 | trace | Remission, off medication |
| 3 | F | 4 | Pred, CyA | MCD | 11 | 6 | Bronchiectasis Hypogamma-globulinemia | 3 | - ve | Remission, on monthly IV IgG replacemen |
| 4 | F | 5 | Pred | MCD | 12 | 4 | No | 10 | - ve | Remission, off medication for 10 years |
| 5 | M | 6 | Pred, CyA, MMF | MCD | 10 | 12 | Anaphylactoid reaction to last dose | 2 | 4+ | Pred, MMF, Tac |
| 6 | M | 4 | Pred, MMF | MCD | 9 | 4 | No | 5 | - ve | Remission, off medication for 5 years |
| 7 | M | 2 | Pred, CyA | MCD | 4 | 4 | No | 3 | - ve | Remission, on low-dose pred |
| 8 | M | 3 | Pred, MMF, CyA | IgM Nephropathy | 6 | 2 | No | 2 | - ve | Remission, on MMF |
| 9 | M | 2 | Pred, MMF | IgM Nephropathy | 4 | 4 | No | 3 | - ve | Remission, off medication |
| 10 | M | 5 | Pred, MMF | MCD | 10 | 3 | No | 9 | - ve | Remission, off medication for 9 years |
| 11 | M | 4 | Pred, MMF | MCD | 8 | 3 | No | 8 | - ve | Remission, off medication for 8 years |
| 12 | M | 6 | Pred, CyA | MCD | 12 | 7 | No | 3 | - ve | Remission, off medication |
| 13 | M | 4 | Pred, CyA | MCD | 6 | 2 | No | 2 | Trace | Remission, off medication |
| 14 | M | 3 | Pred, MMF, Tac | IgM Nephropathy | 5 | 3 | Allergy, itching | 2 | - ve | Remission on MMF |
| 15 | M | 2 | Pred, CyA | FSGS | 4 | 2 | No | 2 | - ve | Remission on CyA |
| 16 | M | 2 | Pred | MCD | 10 | 4 | No | 2 | - ve | Remission, off medication |
| 17 | M | 4 | Pred, CyA | MCD | 13 | 4 | No | 5 | - ve | Remission, off medication for 5 years |
No.: number, y: years, IS: immunosuppressive medication, RTX: rituximab, F: female, M: male, Pred: prednisolone, tac: tacrolimus, MMF: mycophenolate mofetil, CyA: cyclosporine A, MCD: minimal change disease, IgM: immunoglobulin M, FSGS: focal segmental glomerulosclerosis, IgG: immunoglobulin G, IV: intravenous